Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia.

被引:0
|
作者
Tallman, MS
Lee, S
Oken, MM
Cassileth, PA
Bennett, JM
Wiernik, PH
Rowe, JM
机构
[1] Northwestern Univ, Sch Med, Chicago, IL USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Virginia Piper Canc Inst, Minneapolis, MN USA
[4] Univ Miami, Sch Med, Miami, FL USA
[5] Univ Rochester, Ctr Canc, Rochester, NY USA
[6] New York Med Coll, OLM Canc Ctr, Bronx, NY USA
[7] Rambam Med Ctr, Haifa, Israel
[8] ECOG, Brookline, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4205
引用
收藏
页码:224B / 224B
页数:1
相关论文
共 50 条
  • [21] Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission
    Fagioli, Franca
    Zecca, Marco
    Locatelli, Franco
    Lanino, Edoardo
    Uderzo, Cornelio
    Di Bartolomeo, Paolo
    Berger, Massimo
    Favre, Claudio
    Rondelli, Roberto
    Pession, Andrea
    Messina, Chiara
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (08) : 575 - 583
  • [22] Criteria for complete remission in acute myeloid leukemia revisited.
    de Greef, GE
    van Putten, WLJ
    Boogaerts, MA
    Huijgens, PC
    Verdonck, LF
    Vellenga, E
    Theobald, M
    Jacky, E
    Löwenberg, B
    BLOOD, 2003, 102 (11) : 235B - 235B
  • [23] REDUCED INTENSITY VERSUS STANDARD MYELOABLATIVE CONDITIONING IN PATIENTS WITH ACUTE MYELOID LEUKEMIA IN SECOND COMPLETE REMISSION
    Terwey, T. H.
    Hemmati, P. G.
    Vuong, L. G.
    le Coutre, P.
    Massenkeil, G.
    Doerken, B.
    Arnold, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S308 - S308
  • [24] Trends in the outcome of patients with acute myeloid leukaemia transplanted in second complete remission
    Michelis, F. V.
    Gupta, V.
    Kim, D. H.
    Kuruvilla, J.
    Lipton, J. H.
    Loach, D.
    Messner, H. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S100 - S101
  • [25] Persistence of Exosomes in Patients with Acute Myeloid Leukemia in Complete Remission Suppresses Hematopoiesis
    Namburi, Swathi
    Broxmeyer, Hal E.
    Whiteside, Theresa L.
    Boyiadzis, Michael
    BLOOD, 2018, 132
  • [26] Death In Complete Remission Among Patients with Acute Myeloid Leukemia: A Preventable Problem?
    Mattiuzzi, Gloria
    Kantarjian, Hagop
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Faderl, Stefan
    Kadia, Tapan
    Estrov, Zeev
    Iliescu, Gloria
    Pierce, Sherry A.
    Cortes, Jorge E.
    BLOOD, 2010, 116 (21) : 1117 - 1117
  • [27] ACUTE MYELOID LEUCEMIA WITH COMPLETE REMISSION
    BERGSTROM, I
    LJUNGGREN, H
    NORDISK MEDICIN, 1950, 44 (37) : 1482 - 1483
  • [28] Comparison of outcomes between autogous PBSCT with autologous GVHD and allogeneic BMT in the first complete remission of acute myeloid leukemia.
    Park, J
    Lee, MH
    Lee, SH
    Park, SH
    Lee, KE
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Im, YH
    Kang, WK
    Park, K
    BLOOD, 2002, 100 (11) : 473B - 473B
  • [29] Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia
    Araki, Daisuke
    Othus, Megan
    Walter, Roland B.
    Sandhu, Vicky
    Sandmaier, Brenda M.
    Becker, Pamela S.
    Appelbaum, Frederick R.
    Estey, Elihu H.
    HAEMATOLOGICA, 2015, 100 (07) : E254 - E256
  • [30] TANDEM AUTO-ALLO IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS IN FIRST COMPLETE REMISSION (CR)
    Castagna, L.
    Prebet, T.
    Furst, S.
    El-Cheikh, J.
    Charbonnier, A.
    Faucher, C.
    Mohty, M.
    Chabannon, C.
    Vey, N.
    Blaise, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S275 - S275